The 11th International Congress on Targeted Anticancer Therapies, Paris,4-6 March 2013 (TAT 2013)

A range of new and promising targeted drugs currently under development for improved cancer therapy were presented during the 11th International Congress on Targeted Anticancer Therapies, Paris, 4–6 March 2013 (TAT 2013). TAT 2013 was attended by over 500 participants from 46 countries. More th...

Full description

Saved in:
Bibliographic Details
Published in:Experimental Oncology
Date:2013
Main Authors: Samoilenko, O., Zaletok, S.
Format: Article
Language:English
Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2013
Subjects:
Online Access:https://nasplib.isofts.kiev.ua/handle/123456789/145244
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Cite this:The 11th International Congress on Targeted Anticancer Therapies, Paris,4-6 March 2013 (TAT 2013) / O. Samoilenko, S. Zaletok // Experimental Oncology. — 2013. — Т. 35, № 3. — С. 231-235. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id nasplib_isofts_kiev_ua-123456789-145244
record_format dspace
spelling Samoilenko, O.
Zaletok, S.
2019-01-19T21:02:55Z
2019-01-19T21:02:55Z
2013
The 11th International Congress on Targeted Anticancer Therapies, Paris,4-6 March 2013 (TAT 2013) / O. Samoilenko, S. Zaletok // Experimental Oncology. — 2013. — Т. 35, № 3. — С. 231-235. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/145244
A range of new and promising targeted drugs currently under development for improved cancer therapy were presented during the 11th International Congress on Targeted Anticancer Therapies, Paris, 4–6 March 2013 (TAT 2013). TAT 2013 was attended by over 500 participants from 46 countries. More than 60 plenary lectures and 70 posters, presented by leading experts in clinical cancer research and drug development, were devoted to dozens of emerging targeted agents and new drug targets under development for cancer therapy
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Chronicle
The 11th International Congress on Targeted Anticancer Therapies, Paris,4-6 March 2013 (TAT 2013)
Article
published earlier
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
title The 11th International Congress on Targeted Anticancer Therapies, Paris,4-6 March 2013 (TAT 2013)
spellingShingle The 11th International Congress on Targeted Anticancer Therapies, Paris,4-6 March 2013 (TAT 2013)
Samoilenko, O.
Zaletok, S.
Chronicle
title_short The 11th International Congress on Targeted Anticancer Therapies, Paris,4-6 March 2013 (TAT 2013)
title_full The 11th International Congress on Targeted Anticancer Therapies, Paris,4-6 March 2013 (TAT 2013)
title_fullStr The 11th International Congress on Targeted Anticancer Therapies, Paris,4-6 March 2013 (TAT 2013)
title_full_unstemmed The 11th International Congress on Targeted Anticancer Therapies, Paris,4-6 March 2013 (TAT 2013)
title_sort 11th international congress on targeted anticancer therapies, paris,4-6 march 2013 (tat 2013)
author Samoilenko, O.
Zaletok, S.
author_facet Samoilenko, O.
Zaletok, S.
topic Chronicle
topic_facet Chronicle
publishDate 2013
language English
container_title Experimental Oncology
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
format Article
description A range of new and promising targeted drugs currently under development for improved cancer therapy were presented during the 11th International Congress on Targeted Anticancer Therapies, Paris, 4–6 March 2013 (TAT 2013). TAT 2013 was attended by over 500 participants from 46 countries. More than 60 plenary lectures and 70 posters, presented by leading experts in clinical cancer research and drug development, were devoted to dozens of emerging targeted agents and new drug targets under development for cancer therapy
issn 1812-9269
url https://nasplib.isofts.kiev.ua/handle/123456789/145244
citation_txt The 11th International Congress on Targeted Anticancer Therapies, Paris,4-6 March 2013 (TAT 2013) / O. Samoilenko, S. Zaletok // Experimental Oncology. — 2013. — Т. 35, № 3. — С. 231-235. — англ.
work_keys_str_mv AT samoilenkoo the11thinternationalcongressontargetedanticancertherapiesparis46march2013tat2013
AT zaletoks the11thinternationalcongressontargetedanticancertherapiesparis46march2013tat2013
AT samoilenkoo 11thinternationalcongressontargetedanticancertherapiesparis46march2013tat2013
AT zaletoks 11thinternationalcongressontargetedanticancertherapiesparis46march2013tat2013
first_indexed 2025-12-07T17:27:04Z
last_indexed 2025-12-07T17:27:04Z
_version_ 1850871302429081600